{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
MK-677 (also known as Ibutamoren) is an oral, non-peptide growth hormone secretagogue (GHS) and ghrelin receptor agonist. It stimulates the pituitary gland to release human growth hormone (HGH) and raises insulin-like growth factor 1 (IGF-1) levels.
What It Is & How It Works
• Chemical Type: It is a small organic molecule—not a peptide (it is not built from a chain of amino acids).
• Mechanism: It mimics ghrelin (the "hunger hormone") by binding to ghrelin receptors in the brain, triggering a pulsatile release of growth hormone without suppressing your body's natural hormone production.
• Origin: Developed originally by Merck in the 1990s to study conditions like muscle wasting, osteoporosis, and growth hormone deficiency.
Proposed Benefits (In Research & Anecdotal Use)
• Increased lean muscle mass and body composition support.
• Enhanced appetite and caloric intake (frequently used during "bulking" cycles).
• Improved sleep quality and REM patterns.
• Increased bone mineral density and faster soft-tissue recovery.
Risks & Side Effects
• Metabolic Impact: Can significantly reduce insulin sensitivity and elevate fasting blood glucose or HOMA-IR levels, carrying a risk of insulin resistance or type 2 diabetes.
• Appetite & Fluid Changes: Extreme hunger, noticeable water retention, bloating, and joint stiffness.
• Other Effects: Lethargy, increased prolactin, or anxiety.
• Safety Concerns: Clinical development was halted for certain patient groups due to adverse cardiovascular events (such as fluid retention concerns in elderly trial participants).